loader
Please Wait
Applying Filters...

Athena Athena

X

List of Drug Master Files (DMF) for 11692 Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Cambrex Corporation (1)

filter

01 CLOZAPINE (1)

filter

01 U.S.A (1)

filter

01 Active (1)

filter

01 Complete (1)

URL Supplier Web Content
11692
Active
1995-10-03
Complete
2013-10-04
2013-09-30
II
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for Drug Master Files (DMF) for 11692 of Cambrex Profarmaco Milano Srl

Looking for Drug Master Files (DMF) for 11692 of Cambrex Profarmaco Milano Srl 1

20

Cambrex Profarmaco Milano Srl, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for Cambrex is an innovative life sciences company with a refreshingly human approach.

One of their notable products is CLOZAPINE, with a corresponding US DMF Number 11692.

Remarkably, this DMF maintains an Active status since its submission on October 03, 1995, highlighting commitment to regulatory compliance.

Their GDUFA DMF Review was successfully complete, with a review date of October 04, 2013, and payment made on September 30, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II

Post Enquiry
POST ENQUIRY